Cargando…
Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
More than 32,000 patients are diagnosed with pancreatic cancer in the United States per year and the disease is associated with very high mortality (1). Urgent need exists to develop novel clinically-translatable therapeutic strategies that can improve on the dismal survival statistics of pancreatic...
Autores principales: | Xu, Jing, Amiji, Mansoor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400379/ https://www.ncbi.nlm.nih.gov/pubmed/22231028 http://dx.doi.org/10.3791/3612 |
Ejemplares similares
-
Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer
por: Xu, Jing, et al.
Publicado: (2014) -
Pancreatic Cancer Cell Exosome-Mediated Macrophage Reprogramming and the Role of MicroRNAs 155 and 125b2 Transfection using Nanoparticle Delivery Systems
por: Su, Mei-Ju, et al.
Publicado: (2016) -
Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis
por: Brito, Luis A, et al.
Publicado: (2010) -
Mad2 Checkpoint Gene Silencing Using
Epidermal Growth Factor Receptor-Targeted Chitosan Nanoparticles in
Non-Small Cell Lung Cancer Model
por: Nascimento, Ana Vanessa, et al.
Publicado: (2014) -
Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy
por: Peckys, Diana B., et al.
Publicado: (2015)